Capricor Therapeutics Operating Expenses 2010-2024 | CAPR
Capricor Therapeutics operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
| Capricor Therapeutics Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $65 |
| 2023 | $49 |
| 2022 | $32 |
| 2021 | $21 |
| 2020 | $14 |
| 2019 | $9 |
| 2018 | $17 |
| 2017 | $16 |
| 2016 | $21 |
| 2015 | $18 |
| 2014 | $11 |
| 2013 | $7 |
| 2012 | $4 |
| 2011 | $6 |
| 2010 | $6 |
| 2009 | $8 |
| Capricor Therapeutics Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $19 |
| 2024-09-30 | $15 |
| 2024-06-30 | $16 |
| 2024-03-31 | $15 |
| 2023-12-31 | $13 |
| 2023-09-30 | $13 |
| 2023-06-30 | $12 |
| 2023-03-31 | $11 |
| 2022-12-31 | $9 |
| 2022-09-30 | $8 |
| 2022-06-30 | $7 |
| 2022-03-31 | $8 |
| 2021-12-31 | $6 |
| 2021-09-30 | $4 |
| 2021-06-30 | $5 |
| 2021-03-31 | $5 |
| 2020-12-31 | $4 |
| 2020-09-30 | $4 |
| 2020-06-30 | $4 |
| 2020-03-31 | $2 |
| 2019-12-31 | $2 |
| 2019-09-30 | $2 |
| 2019-06-30 | $2 |
| 2019-03-31 | $3 |
| 2018-12-31 | $4 |
| 2018-09-30 | $4 |
| 2018-06-30 | $5 |
| 2018-03-31 | $4 |
| 2017-12-31 | $4 |
| 2017-09-30 | $3 |
| 2017-06-30 | $4 |
| 2017-03-31 | $4 |
| 2016-12-31 | $4 |
| 2016-09-30 | $6 |
| 2016-06-30 | $6 |
| 2016-03-31 | $5 |
| 2015-12-31 | $4 |
| 2015-09-30 | $4 |
| 2015-06-30 | $4 |
| 2015-03-31 | $5 |
| 2014-12-31 | $3 |
| 2014-09-30 | $3 |
| 2014-06-30 | $3 |
| 2014-03-31 | $2 |
| 2013-12-31 | $2 |
| 2013-09-30 | $2 |
| 2013-06-30 | $2 |
| 2013-03-31 | $2 |
| 2012-12-31 | $2 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $2 |
| 2011-09-30 | $2 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $2 |
| 2010-06-30 | $2 |
| 2010-03-31 | $2 |
| 2009-12-31 | $2 |
| 2009-09-30 | $2 |
| 2009-06-30 | $3 |
| 2009-03-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.582B | $0.022B |
| Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California. | |||